SEC Filings

For all investor or media inquiries, visit https://www.adaptimmune.com/contact.

Filing date	Description	Form	Filing Group	View
Jun 01, 2023	Statement of changes in beneficial ownership of securities	4	3,4,5	0001104659-23-067078.pdf 0001104659-23-067078.rtf 0001104659-23-067078.xls View HTML
Jun 01, 2023	Statement of changes in beneficial ownership of securities	4	3,4,5	0001104659-23-067082.pdf 0001104659-23-067082.rtf 0001104659-23-067082.xls View HTML
Jun 01, 2023	Post-effective amendment to an S-8 filing	S-8 POS	Registration Statements	0001104659-23-067090.pdf 0001104659-23-067090.rtf View HTML
Jun 01, 2023	Post-effective amendment to an S-8 filing	S-8 POS	Registration Statements	0001104659-23-067092.pdf 0001104659-23-067092.rtf View HTML
Jun 01, 2023	Post-effective amendment to an S-8 filing	S-8 POS	Registration Statements	0001104659-23-067095.pdf 0001104659-23-067095.rtf View HTML
Jun 01, 2023	Post-effective amendment to an S-8 filing	S-8 POS	Registration Statements	0001104659-23-067098.pdf 0001104659-23-067098.rtf View HTML
Jun 01, 2023	Post-effective amendment to an S-Type filing	POS AM	Registration Statements	0001104659-23-067102.pdf 0001104659-23-067102.rtf View HTML
Jun 01, 2023	Post-effective amendment to an S-8 filing	S-8 POS	Registration Statements	0001104659-23-067097.pdf 0001104659-23-067097.rtf View HTML
Jun 01, 2023	Post-effective amendment to an S-Type filing	POS AM	Registration Statements	0001104659-23-067103.pdf 0001104659-23-067103.rtf View HTML
Jun 01, 2023	Post-effective amendment to an S-Type filing	POS AM	Registration Statements	0001104659-23-067104.pdf 0001104659-23-067104.rtf View HTML

Data provided by Kaleidoscope.